Search Videos and More
Drug developed by UTSW spinoff approved for metastatic kidney cancer
FDA’s expanded use for belzutifan culminates nearly 30-year journey from gene discovery to first-in-class drug discoveryUTSW among first in nation to offer biology-guided radiotherapy
Novel technology at Simmons Cancer Center can target bone or lung cancer sites in a single sessionInside the OR: Robotic Pancreatic Surgery
The Whipple procedure is one of the most technically challenging abdominal surgeries – and it is also a UT Southwestern specialty. In this video, Dr. Herbert Zeh, Chair of our Department of Surgery, and Dr. Patricio Polanco, a GI and robotic surgery expert, take you inside the operating room for a firsthand look at this complex surgery.Three drugs target resistant breast cancers driven by HER2 mutations
New regimen added to national treatment guidelines based on results of study co-led by UT SouthwesternEmergency room visits by cancer patients can often be avoided
Most don’t seek advice from nurse triage lines before heading to the hospital, UTSW study showsPancreatic Cancer: Catching It Before It's Too Late
Highly experienced, multidisciplinary care team offers hope for patients.Lifelong Care for Pediatric Cancer Survivors
The After Cancer Experience (ACE) Program builds a solid foundation for long-term surveillance and treatment.Therapeutic Targeting of Septin Proteins: A New Pan-Cancer Focus?
Research into cell configurations uncovers vulnerability that could be leveraged to treat multiple cancer types.Advancing the Treatment of Brain Tumors
As both a researcher and a neurosurgeon, Toral Patel, M.D., is uniquely experienced to offer the highest level of care for patients with malignant or benign brain tumors.Combating Uveal Melanoma with New Treatments
UT Southwestern Harold C. Simmons Comprehensive Cancer Center is a leader in the diagnosis and treatment of uveal melanoma, the most common primary intraocular malignancy. J. William Harbour, M.D., who was recruited to UT Southwestern as Chair and Professor of Ophthalmology in 2021, is an internationally recognized authority on uveal melanoma.
News
Fluorescent Nanoprobe Produces ‘Breakthrough’ for Peritoneal Metastases
This flourescent nanoprobe enhances the visibility of tumor edges, allowing surgeons to remove more cancer cells than standard imaging technology. Learn how the technology works.Same-Day Clinic Streamlines Acute Care
Oncology urgent care specialists at Simmons Acute Care (SAC) provide acute care for cancer symptoms, keeping patients out of the emergency department. Learn more.